INTS · Intensity Therapeutics, Inc. · Analyst Estimates
$4.04
+0.02 (+0.50%)
At close · Sep 10
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the cash and cash equivalents as of June 30, 2026, the Company's ability to continue its operations thereafter is dependent on obtaining additional capital, which is not within the Company's control. As a result, the Company believes there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$13.19M
Shares
3.26M
Analyst Estimates
Compare analyst forecasts for Intensity Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Source collection is delayed; the retained verified snapshot may not include newer publications.
Consensus not yet available
Source collection is delayed; the retained verified snapshot may not include newer publications.
Key facts
CIK
1567264
CUSIP
45828J202
13F (30d)
11 filings
10 filers
Visit website
Investor relations